174 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Grunenthal Acquisitions

Grunenthal has acquired 9 companies and its latest acquisition was STIVARGA on Sep 2026

Unlock 6 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
STIVARGA

Sep 2026

Source »
$431M
-
Valinor Pharma, LLC

Jul 2024

Source »
$250M
Valinor Pharma is an Illinois-based pharmaceutical company that develops and markets drugs to treat constipation caused by opioid drugs.
MOVANTIK

Jul 2024

Source »
undisclosed
MOVANTIK is an Illinois-based pharmaceutical company that develops and markets drugs to treat constipation caused by opioid drugs.
Nebido

Jul 2022

Source »
$505.5M
Nebido is a Germany-based pharmaceutical company that develops and commercializes injectable testosterone therapies for the treatment of male hypogonadism.
Mestex AG

Apr 2021

Source »
undisclosed
Mestex is a Switzerland-based biotech company that develops and commercializes investigational medicines for the treatment of osteoarthritis.

Frequently Asked Questions about Grunenthal

  1. What companies did Grunenthal acquire?

    Companies acquired by Grunenthal include STIVARGA, Valinor Pharma and MOVANTIK

  2. How many acquisitions does Grunenthal have?

    Grunenthal has acquired 9 companies including STIVARGA, Valinor Pharma and MOVANTIK.

  1. How many acquisitions did Grunenthal make in 2026?

    In 2026 Grunenthal acquired 1 companies including STIVARGA.